US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist
  • 1.380
  • +0.030+2.22%
Trading Nov 19 11:54 ET
189.87MMarket Cap-3942P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Compass Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q2850.000K / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Compass Therapeutics Earnings Reports

  • Compass Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 12:23 ET

  • Compass Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 08:05 ET

  • Compass Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 08:04 ET

  • Compass Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 09:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data